Avantor (NYSE:AVTR) released its quarterly earnings data on Wednesday. The company reported $0.19 EPS for the quarter, beating the Zacks’ consensus estimate of $0.14 by $0.05, MarketWatch Earnings reports. The firm had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.49 billion. During the same quarter in the prior year, the company earned $0.14 EPS. Avantor’s quarterly revenue was down 3.5% on a year-over-year basis.

NYSE:AVTR traded up $2.37 during mid-day trading on Thursday, hitting $22.01. The stock had a trading volume of 115,494 shares, compared to its average volume of 4,433,258. The stock has a market cap of $12.62 billion, a price-to-earnings ratio of -26.34, a PEG ratio of 1.45 and a beta of 2.01. Avantor has a twelve month low of $6.66 and a twelve month high of $19.96. The company’s 50 day simple moving average is $17.87 and its 200 day simple moving average is $16.45.

In other Avantor news, EVP Devashish Ohri sold 65,000 shares of the stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $18.84, for a total value of $1,224,600.00. Following the transaction, the executive vice president now directly owns 181,671 shares of the company’s stock, valued at approximately $3,422,681.64. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Jo Natauri sold 13,726,411 shares of the stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $15.90, for a total transaction of $218,249,934.90. The disclosure for this sale can be found here. Over the last three months, insiders sold 34,726,317 shares of company stock worth $552,420,898. Insiders own 1.90% of the company’s stock.

A number of research firms recently commented on AVTR. Stifel Nicolaus upped their price objective on shares of Avantor from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Thursday, April 30th. Cleveland Research raised shares of Avantor from a “neutral” rating to a “buy” rating in a research note on Wednesday, July 15th. Credit Suisse Group upped their target price on shares of Avantor from $18.00 to $21.00 and gave the stock an “outperform” rating in a research note on Tuesday. CSFB reduced their price objective on shares of Avantor from $20.00 to $18.00 and set an “outperform” rating for the company in a research note on Thursday, April 30th. Finally, JPMorgan Chase & Co. restated an “overweight” rating and set a $25.00 price objective (up from $18.00) on shares of Avantor in a research note on Thursday. Four analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $20.38.

Avantor Company Profile

Avantor, Inc is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates in more than 30 countries and deliver an extensive portfolio of products and services.

Further Reading: Holder of Record

Earnings History for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.